INITIAL DRUG TREATMENT IN PARKINSON'S DISEASE Reboxetine has no antidepressant effect at all

被引：3
作者：
Braithwaite, Richard [1 ]
机构：
[1] St Marys Hosp, Newport PO30 5TG, Gwent, Wales
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2015年 / 351卷
关键词：
D O I：
10.1136/bmj.h5842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 3 条
[1]  
[Anonymous], 2020, THESIS U TASMANIA
[2]   Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials [J].
Eyding, Dirk ;
Lelgemann, Monika ;
Grouven, Ulrich ;
Haerter, Martin ;
Kromp, Mandy ;
Kaiser, Thomas ;
Kerekes, Michaela F. ;
Gerken, Martin ;
Wieseler, Beate .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :816
[3]   Initial drug treatment in Parkinson's disease [J].
Muzerengi, Sharon ;
Clarke, Carl E. .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
1